menu

 
















Research & Development Database

In order to have access to the database you need to register/login on our website first.
Overview
Example

Introduction

You are very welcome to use our R&D projects database on the following conditions.

The database is payable as it is based on personal contacts with project leaders, whom we may also connect you with.

Below, you could read statistical data on the projects numbers, which are additionally divided into biotech-related sectors to give you an idea about the content.
Moreover, in the next tab we provide you with an example of a fictive R&D project, to present the way the data are organized in a single record. The example will be replaced by the exact database content upon subscription.
The database user has also on opportunity of collecting chosen project descriptions in a personal basket, which keeps content for the whole subscription period.

The database is currently intensively developing, therefore, the 3-month subscription is more profitable option. Statistical data on this site will adjust to the constantly extending database.

In the next step, the database projects will be further described and their commercialization potential will be gradually evaluated, increasing value of the provided data. Please note that by then, the initial not yet evaluated projects are based mainly on the information from their leaders.

The aim is to gather remarkable numbers of projects coming from laboratories of Central Europe, in order to show the biotech-related potential of the region.

Subscription

It is necessary to register on CEBiotech.com to view this database.
If you have registered your account already, you may subscribe for the R&D projects database access on your account page.

Statistics

All projects: 32

divided into

sectors:

Bioproducts
Bioremediation
Diagnostics
Immunity boosting
Lab equipment & reagents
Nutrition
Pharmaceuticals
Plant protection
Regenerative medicine


5
4
9
1
1
2
8
1
1
countries of origin:

Hungary
Poland


1
31

Database author

Bio-Tech Consulting exists in the consulting market of pharmacy and biotechnology for over 10 years now. Our mission is promoting introduction of modern biotechnologies into the Bioeconomy sector. Thus, we intend to become the most important partner for scientists and businessmen in the process of fast implementation of scientific achievements into the business practice, as well as creating company's development potential on the basis of knowledge and its power to yield economical successes.
We stimulate, organize and coordinate cooperation of capital investors, innovative companies and scientists in the Bioeconomy sector. We create databases and advanced channels of scientific and business information flow for this environment. We also assess commercialization potential of scientific projects and provide professional trainings.

Contact

In case of any inquiries or special requests you are very welcome to contact us.
We especially appreciate your feedback on the service in order to adjust it to your needs.

Magdalena Zychlinska Ph.D.
magdalena.zychlinska@biotechconsulting.pl
phone +48 42 299 6085, mobile +48 600 812 332

EXAMPLE - fictive R&D project
Sector: Diagnostics

EXAMPLE - FICTIVE R&D PROJECT: Quick screen for tumor markers

project leader
ZYCHLINSKA Magdalena, PhD - Database manager
magdalena.zychlinska@biotechconsulting.pl
phone: +48 42 299 6085, +48 600 812 332
Poland
90-229 Lodz, Kaminskiego 23
from
company
Bio-Tech Consulting Ltd
product/technology
CANCER DETECTION TEST
The diagnostic array allows for an immediate determination of increased values of tumor markers.

Special features
Diagnosis of already advanced tumors frequently results in high mortality rates.
Detection via tumor markers enables early prognosis and so, better survival.

The test mechanism is based on immunoassay and is provided in form of small detector reading sample diagnostic strips. Chip format encloses a chosen set of most important protein markers (BRCA, PSA, CA125) permitting broad screen for increased tumor risk.

Suggested application
The device can be easily operated by a doctor at private medical practice, in hospital or health centre. The results are given to patients during the same visit.
Patients with increased cancer risk (e.g. strong family history) could be easily checked for the present risk status.
IPR status:
Patent
project stage:
In vivo studies
Partners: